CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 20,176 shares at an average $17.93 ($361,690)
- 4 Open-market sale President and CSO sold 8,000 shares at $18.05 ($144,400)
- 4 Open-market sale President and CSO sold 20,000 shares at $15.07 ($301,354)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 31,677 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CSO gave up 14,134 shares (to pay taxes)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,251 shares at $14.21 ($17,783)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 4 Open-market sale PRESIDENT AND CSO sold 20,000 shares at $15.23 ($304,646)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 3,400 shares at $14.72 ($50,051)
- 10-Q Report Quarterly Report
Page 15 of 28 · 553 filings